SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy

被引：2

作者：

Sun, Lova ^{[1
]}

Surya, Sanjna ^{[1
]}

Goodman, Noah G. ^{[1
]}

Le, Anh N. ^{[1
]}

Kelly, Gregory ^{[1
]}

Owoyemi, Olutosin ^{[1
]}

Desai, Heena ^{[1
]}

Zheng, Cathy ^{[1
]}

DeLuca, Shannon ^{[1
]}

Good, Madeline L. ^{[1
]}

Hussain, Jasmin ^{[2
]}

Jeffries, Seth D. ^{[1
]}

Kry, Yolanda R. ^{[2
]}

Kugler, Emily M. ^{[1
]}

Mansour, Maikel ^{[2
]}

Ndicu, John ^{[1
]}

Osei-Akoto, Annaclaire ^{[3
]}

Prior, Timothy ^{[2
]}

Pundock, Stacy L. ^{[1
]}

Varughese, Lisa A. ^{[3
]}

Weaver, JoEllen ^{[3
]}

Doucette, Abigail ^{[4
]}

Dudek, Scott ^{[3
]}

Verma, Shefali Setia ^{[3
]}

Gouma, Sigrid ^{[5
]}

Weirick, Madison E. ^{[5
]}

McAllister, Christopher M. ^{[5
]}

Bange, Erin ^{[1
]}

Gabriel, Peter ^{[4
,6
]}

Ritchie, Marylyn ^{[3
]}

Rader, Daniel J. ^{[3
]}

Vonderheide, Robert H. ^{[1
,6
]}

Schuchter, Lynn M. ^{[1
,6
]}

Verma, Anurag ^{[3
]}

Maillard, Ivan ^{[1
,6
]}

Mamtani, Ronac ^{[1
,6
]}

Hensley, Scott E. ^{[5
]}

Gross, Robert ^{[7
]}

Wileyto, E. Paul ^{[8
]}

Huang, Alexander C. ^{[1
,6
]}

Maxwell, Kara N. ^{[1
,3
,6
]}

DeMichele, Angela ^{[1
,6
]}

机构：

[1] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA USA

[2] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA USA

[3] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA USA

[4] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA USA

[5] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA

[6] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[7] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA USA

[8] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA USA

来源：

JCO ONCOLOGY PRACTICE | 2021年 / 17卷 / 12期

基金：

美国国家卫生研究院;

关键词：

COVID-19; IMPACT;

D O I：

10.1200/OP.21.00113

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PURPOSE Multiple studies have demonstrated the negative impact of cancer care delays during the COVID-19 pandemic, and transmission mitigation techniques are imperative for continued cancer care delivery. We aimed to gauge the effectiveness of these measures at the University of Pennsylvania. METHODS We conducted a longitudinal study of SARS-CoV-2 antibody seropositivity and seroconversion in patients presenting to infusion centers for cancer-directed therapy between May 21, 2020, and October 8, 2020. Participants completed questionnaires and had up to five serial blood collections. RESULTS Of 124 enrolled patients, only two (1.6%) had detectable SARS-CoV-2 antibodies on initial blood draw, and no initially seronegative patients developed newly detectable antibodies on subsequent blood draw(s), corresponding to a seroconversion rate of 0% (95% CI, 0.0 TO 4.1%) over 14.8 person-years of follow up, with a median of 13 health care visits per patient. CONCLUSION These results suggest that patients with cancer receiving in-person care at a facility with aggressive mitigation efforts have an extremely low likelihood of COVID-19 infection. (C) 2021 by American Society of Clinical Oncology

引用

页码：748 / +

页数：9

共 50 条

[31] Impfung gegen SARS-CoV-2 bei KrebspatientenVaccination against SARS-CoV-2 in cancer patients
Marie von Lilienfeld-Toal
Christina Rieger
Nicola Giesen
Bernhard Wörmann
Der Onkologe, 2021, 27 : 691 - 696
[32] A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat
Daniel Stadlbauer
Shirin Strohmeier
Thi H. O. Nguyen
Veronika Chromikova
Meagan McMahon
Kaijun Jiang
Guha Asthagiri Arunkumar
Denise Jurczyszak
Jose Polanco
Maria Bermudez-Gonzalez
Giulio Kleiner
Teresa Aydillo
Lisa Miorin
Daniel S. Fierer
Luz Amarilis Lugo
Erna Milunka Kojic
Jonathan Stoever
Sean T. H. Liu
Charlotte Cunningham-Rundles
Philip L. Felgner
Thomas Moran
Adolfo García-Sastre
Daniel Caplivski
Allen C. Cheng
Katherine Kedzierska
Olli Vapalahti
Jussi M. Hepojoki
Viviana Simon
Florian Krammer
Nature Medicine, 2020, 26 : 1033 - 1036
[33] Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment
Webber, Tania Buttiron
Provinciali, Nicoletta
Musso, Marco
Ugolini, Martina
Boitano, Monica
Clavarezza, Matteo
D'Amico, Mauro
Defferrari, Carlotta
Gozza, Alberto
Briata, Irene Maria
Magnani, Monica
Paciolla, Fortuna
Menghini, Nadia
Marcenaro, Emanuela
De Palma, Raffaele
Sacchi, Nicoletta
Innocenti, Leonello
Siri, Giacomo
D'Ecclesiis, Oriana
Cevasco, Isabella
Gandini, Sara
DeCensi, Andrea
EUROPEAN JOURNAL OF CANCER, 2021, 159 : 105 - 112
[34] Factors associated with seropositivity for SARS-CoV-2 in patients treated at a hospital in the Peruvian highlands
Vera-Ponce, Victor J.
Mendez-Aguilar, Paul
Ichiro-Peralta, C.
Failoc-Rojas, Virgilio E.
Valladares-Garrido, Mario J.
REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2021, 14 : 8 - 12
[35] Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the US
Anand, Shuchi
Montez-Rath, Maria E.
Han, Jialin
Garcia, Pablo
Bozeman, Julie
Kerschmann, Russell
Beyer, Paul
Parsonnet, Julie
Chertow, Glenn M.
PLOS ONE, 2021, 16 (04):
[36] Efficacy (and safety) of vaccination against SARS-CoV-2 in cancer patients on active treatment
Tina, Zupancic
Cvetka, Grasic Kuhar
ONKOLOGIJA, 2021, 25 (02) : 42 - 46
[37] SARS-CoV-2 Seropositivity in Nursing Home Staff and Residents during the First SARS-CoV-2 Wave in Flanders, Belgium
De Rop, Liselore
Vercruysse, Hanne
Alenus, Ulysse
Brusselmans, Judith
Callens, Steven
Claeys, Maud
De Coene, Nimphe
Persyn, Peter
Padalko, Elizaveta
Heytens, Stefan
Verbakel, Jan Y.
Cools, Piet
VIRUSES-BASEL, 2024, 16 (09):
[38] Commentary: SARS-CoV-2 vaccines and cancer patients
Corti, C.
Curigliano, G.
ANNALS OF ONCOLOGY, 2021, 32 (04) : 569 - +
[39] Cancer patients during SARS-CoV-2 infection
Science Foundation in China, 2020, (01) : 31 - 31
[40] SARS-COV-2 in Colorectal Cancer of IBD Patients
Watts, M. M. Bosca
Navarro, S.
Rosello, S.
Varela, J. M.
Gonzalez, S.
Fernandez, U.
Sanahuja, A.
Mongort, C.
Garcia, T.
Suria, C.
Tosca, J.
Anton, R.
Merino, V
Ponce, M.
Villagrasa, R.
Pla, V
Moro, D.
Casado, D.
Navarro, D.
Pascual, I
JOURNAL OF CROHNS & COLITIS, 2025, 19 : I757 - I756

← 1 2 3 4 5 →